← Back to Search

Local Anesthetic

3D Dental Scan-Guided Anesthesia for Mandibular Nerve Blocks

N/A
Recruiting
Research Sponsored by Louisiana State University Health Sciences Center in New Orleans
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female patients aged 18 to 70 years old assigned to the 3 clinicians of the graduating class of LSUHSC School of Dentistry Post-graduate Periodontics program
Patients missing one or more mandibular teeth and treatment planned for a mandibular implant requiring an inferior alveolar nerve block during surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours
Awards & highlights

Study Summary

This trial looks at whether a 3D dental scan can help guide a lower jaw anesthesia injection to improve the success rate.

Who is the study for?
This trial is for adults aged 18-70 who need a lower jaw nerve block for dental implant surgery and have had no allergic reactions to lidocaine. They must be patients of certain LSUHSC School of Dentistry clinicians, classified as ASA I or II (low risk), missing some lower jaw teeth, and either have or will get a 3D dental scan.Check my eligibility
What is being tested?
The study compares the success rates between two methods of administering anesthesia to the lower jaw: one using a standard technique and the other guided by a pre-treatment 3D dental scan (CBCT).See study design
What are the potential side effects?
Possible side effects include typical reactions to local anesthetics like numbness beyond the targeted area, minor pain at injection site, dizziness, or in rare cases, an allergic reaction.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old and a patient of a specific LSUHSC dental program.
Select...
I am missing one or more lower jaw teeth and need a dental implant that requires nerve block.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hypesthesia
Hypesthesia
Mental nerve numbness
Secondary outcome measures
Pain during surgery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CBCT firstExperimental Treatment1 Intervention
This group will receive the injection technique that is guided by pre-treatment measurements made from the 3D dental scan (CBCT) during implant placement surgery and if the implant is placed as a two-stage procedure, during the second stage implant uncovery will receive the standard injection technique. If the implant is placed as a one-stage procedure, the second visit will not apply.
Group II: Standard technique firstActive Control1 Intervention
This group will receive the standard injection technique first at the implant placement surgery and if the implant is placed as a two-stage procedure, during the second stage implant uncovery will receive the injection technique guided by the 3D dental scan (CBCT). If the implant is placed as a one-stage procedure, the second visit will not apply.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
2% Lidocaine with 1:100,000 epinephrine
2011
N/A
~100

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center in New OrleansLead Sponsor
113 Previous Clinical Trials
43,986 Total Patients Enrolled

Media Library

2% Lidocaine with 1:100,000 epinephrine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT05406895 — N/A
Inferior Alveolar Nerve Research Study Groups: Standard technique first, CBCT first
Inferior Alveolar Nerve Clinical Trial 2023: 2% Lidocaine with 1:100,000 epinephrine Highlights & Side Effects. Trial Name: NCT05406895 — N/A
2% Lidocaine with 1:100,000 epinephrine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05406895 — N/A
Inferior Alveolar Nerve Patient Testimony for trial: Trial Name: NCT05406895 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who has the capacity to participate in this research program?

"This investigation is in search of 200 individuals, aged 18 to 70 years old and with a diagnosis of inferior alveolar nerve. Moreover, the participants must be either male or female and enrolled at LSUHSC School of Dentistry Post-graduate Periodontics program under one of three different medical practitioners. Additionally, they should not have had any known allergic reactions to lidocaine from previous dental treatments; furthermore, these patients require mandibular implant placement that necessitates an inferior alveolar nerve block for surgical intervention as well as possessing CBCT scans done within the past year (or planned) for such purpose."

Answered by AI

How many participants have voluntarily joined this research initiative?

"Affirmative. Clinicaltrials.gov attests that this research project, which was first made public on May 25th 2022 is actively sourcing participants. With the aim of enrolling 200 patients at a single centre."

Answered by AI

Is it feasible for people to join this research initiative presently?

"Per the data posted on clinicaltrials.gov, this particular medical trial is actively recruiting patients. The study was posted to the site initially on May 25th 2022 and has been updated as recently October 25th 2022."

Answered by AI

Does your trial encompass elderly individuals as participants?

"As per the study's entry requirements, individuals between 18 and 70 years of age are eligible for enrollment. Separate clinical trials exist for minors and seniors over 65."

Answered by AI

Who else is applying?

What state do they live in?
Louisiana
What site did they apply to?
Louisiana State University School of Dentistry
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

This is a way to help advance medicine for a better, healthier future for people the only way I can.
PatientReceived 2+ prior treatments
~81 spots leftby Jun 2025